「to you」の検索結果
100件：46～50件目を表示
もしかして
-
esident: Mr. Shuhei Yoshida; hereinafter “Senju”) hereby announces that the orphan drug designation to the in-house developed compound having the development code SJP-0008 was granted by the Ministry ...
https://www.senju.co.jp/system/files/content_news/2024-07/ENG_20240708.pdf -
compound (development code: SJP-0132) discovered by Mochida Pharmaceutical Co., Ltd. (Head office: Tokyo, Japan; President: Mr. Naoyuki Mochida; hereinafter: Mochida) as an eye drop treatment for Dry...
https://www.senju.co.jp/system/files/content_news/2024-07/ENG_20240716.pdf -
ntagonist (development code: SJP-0132) discovered by Mochida Pharmaceutical Co., Ltd. (Head office: Tokyo, Japan; President: Mr. Naoyuki Mochida; hereinafter: Mochida) and licensed to Senju as an eye ...
https://www.senju.co.jp/system/files/content_news/2025-01/ENG_20250117_0.pdf -
Overseas Activities | SENJU Pharmaceutical
h and pharmaceutical development have no borders. We engage in international activities with a view to the future of pharmaceuticals, transcending national and corporate boundaries. As we enter the er...
https://www.senju.co.jp/english/global/ -
ntagonist (development code: SJP-0132) discovered by Mochida Pharmaceutical Co., Ltd. (Head office: Tokyo, Japan; President: Mr. Naoyuki Mochida; hereinafter: Mochida) and licensed to Senju as an eye ...
https://www.senju.co.jp/system/files/content_news/2025-01/ENG_20250117.pdf